These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 467891)

  • 1. Suppression of naturally occurring anti-tissue antibodies during growth and after removal of tumours.
    Chandradasa KD; Elson CJ
    Gan; 1979 Jun; 70(3):261-6. PubMed ID: 467891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit antibodies to nucleoli of Novikoff hepatoma and normal liver of the rat.
    Busch RK; Daskal I; Spohn WH; Kellermayer M; Busch H
    Cancer Res; 1974 Sep; 34(9):2362-7. PubMed ID: 4367290
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of antibody in the inhibition of the growth of Meth.A tumour in syngeneic experiments in vivo and in vitro.
    Farram E; Festenstein H; de Giorgi L
    Clin Exp Immunol; 1978 Sep; 33(3):377-85. PubMed ID: 737892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes in rats bearing chemically induced tumours. II. Characterization of sera from different stages of tumour growth.
    Höffken K; Price MR; Moore VE; Baldwin RW
    Int J Cancer; 1978 Nov; 22(5):576-82. PubMed ID: 214404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to naturally occurring rat sarcomas.
    Embleton MJ; Middle JG
    Br J Cancer; 1981 Jan; 43(1):44-52. PubMed ID: 7459236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-fixing soluble antigen from rat lymphoma (C58NT)D. Preliminary characterization of the antigen and some positive human sera.
    Chorváth B; Hlubinová K; Simkovic D
    Neoplasma; 1978; 25(3):279-83. PubMed ID: 79985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumour antibodies in normal mouse sera.
    Martin SE; Martin WJ
    Int J Cancer; 1975 Apr; 15(4):658-64. PubMed ID: 1140865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to ATPC+ascites tumour in mice rendered resistant by intravenous inoculation of liver cells.
    Pitzurra M; Marconi P
    Boll Ist Sieroter Milan; 1972; 51(5):393-404. PubMed ID: 4656954
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody to carcinoembryonic antigen in hamsters bearing GW-39 human tumors.
    Primus FJ; Wang RH; Cohen E; Hansen HJ; Goldenberg DM
    Cancer Res; 1976 Jul; 36(7 PT 1):2176-81. PubMed ID: 819127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytotoxic natural anti-tumor antibodies against fibrosarcoma and glioma cells in rats (author's transl)].
    Itaya T
    Hokkaido Igaku Zasshi; 1981 Sep; 56(5):499-506. PubMed ID: 7319460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guinea pig tumor-specific natural antibodies in normal rabbit sera.
    Borsos T; Oanian SH
    J Natl Cancer Inst; 1974 Dec; 53(6):1827-9. PubMed ID: 4436873
    [No Abstract]   [Full Text] [Related]  

  • 13. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
    Wasfie T; Reed E; Suciu-Foca N; Hardy MA
    Surgery; 1990 Aug; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data on the cytotoxicity of anti-tumour sera.
    Elek G; Vekerdi L
    Acta Microbiol Acad Sci Hung; 1966-1967; 13(4):267-76. PubMed ID: 4963381
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological competence of spleen cells from rats bearing syngeneic or autochthonous tumours.
    Medzihradský J; Koníková E; Novotná L
    Neoplasma; 1972; 19(2):105-10. PubMed ID: 4401919
    [No Abstract]   [Full Text] [Related]  

  • 16. Host responses in adjuvant contact suppression of experimental rat tumours.
    Pimm MV; Hopper DG; Baldwin RW
    Dev Biol Stand; 1977 Apr 13-15; 38():349-54. PubMed ID: 344098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.
    Hewitt HB; Blake ER; Walder AS
    Br J Cancer; 1976 Mar; 33(3):241-59. PubMed ID: 773395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.
    Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M
    Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does antibody-dependent epitope masking permit progressive tumour growth in the face of cell-mediated cytotoxicity?
    Manson LA
    Immunol Today; 1991 Oct; 12(10):352-5. PubMed ID: 1720318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An IgM-producing immunocytoma induces large numbers of splenic T lymphocytes with Fc mu receptors.
    Uher F; Puskás E; Gergely J; Bazin H
    Immunology; 1987 Jul; 61(3):327-32. PubMed ID: 3497090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.